Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes (Q30825326)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes
scientific article

    Statements

    Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes (English)
    Verteporfin Roundtable 2000 and 2001 Participants
    Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators
    Verteporfin in photodynamic therapy (VIP) study group principal investigators
    1 February 2002

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit